Revance to Release Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 26, 2019
Conference Call Scheduled for
Individuals interested in listening to the conference call may do so by dialing (855) 453-3827 for domestic callers, or (484) 756-4301 for international callers and reference conference ID: 2298778; or from the webcast link in the investor relations section of the company's website at: www.revance.com.
A replay of the call will be available beginning
About
"Revance Therapeutics" and the Revance logo are registered trademarks of
View source version on businesswire.com: https://www.businesswire.com/news/home/20190212005114/en/
Source:
INVESTORS
Revance Therapeutics, Inc.:
Jeanie Herbert,
714-325-3584
jherbert@revance.com
or
Burns
McClellan, Inc.:
John Grimaldi, 212-213-0006
jgrimaldi@burnsmc.com
or
MEDIA
General Media:
TOGORUN:
Mariann Caprino,
917-242-1087
m.caprino@togorun.com
or
Trade
Media:
Nadine Tosk, 504-453-8344
nadinepr@gmail.com